Skip to content

The Study on the effect of oxycodone combined with propofol on visceral pain during artificial abortion in patients with preoperative anxiety

The Study on the effect of oxycodone combined with propofol on visceral pain during artificial abortion in patients with preoperative anxiety

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076169
Enrollment
Unknown
Registered
2023-09-26
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

visceral pain

Interventions

Anxiety group (group A):Sequential experiment: The initial dose of propofol is 3.5 mg/kg. The common dose ratio of propofol for patients is 0.9. If a positive reaction occurs, the next patient will in
Non-anxiety group (group C):Sequential experiment: The initial dose of propofol is 3.5 mg/kg. The common dose ratio of propofol for patients is 0.9. If a positive reaction occurs, the next patient wil

Sponsors

The People's Hospital of Qiannan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Painless artificial abortion was performed under general anesthesia. The age was 18-50 years old and the body mass index was 18-25 kg / m2 ASA ? ~ ?.

Exclusion criteria

Exclusion criteria: Patients with long-term use of opioids, antianxiety drugs, antidepressants, history of alcohol or drug abuse, neurological or mental illness, and inability to complete the anxiety scale. 30min was evaluated by patients themselves with self-rating anxiety scale (SAS) before operation.

Design outcomes

Primary

MeasureTime frame
Visceral pain;

Secondary

MeasureTime frame
MAP;HR;SPO2;adverse reactions;Agitation during awakening;

Countries

China

Contacts

Public ContactChen Lvlv

The People's Hospital of Qiannan

CHENLULUzan@163.com+86 182 7088 4093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026